Investors
CENTERLINE BIOMEDICAL OVERVIEW
About
Centerline Biomedical is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS) technology — an innovative, 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
HISTORY
Founded at Cleveland Clinic following the vision of renowned vascular surgeon, Roy Greenberg, MD
PROBLEM
Radiation emitting, 2D grayscale fluoroscopy has remained mainly unchanged for decades
SOLUTION
IOPS® (Intra-Operative Positioning System) 3D surgical navigation platform technology
TEAM
Well experienced leadership team averaging 20+ years in healthcare
ADVISORY BOARD
Scientific advisory board: Matthew Eagleton, MD (Mass General), Robert Beasley, MD (Mt. Sinai), Mark Farber, MD (UNC Hospitals), Azeem Latib, MD BCh (Montefiore), Gustavo Oderich, MD (UTHealth & Memorial Hermann), Federico Ezequiel Parodi, MD (UNC Hospitals), Peter Rasmussen, MD, FAHA, FAANS, FSNIS (Cleveland Clinic), Karl West, MS (Cleveland Clinic)
HIGHLIGHTS
FDA Cleared
Intellectual Property
Rich and growing IP portfolio with 29 issued and 48 pending patents
Strategic Partnerships
Strong commercial partnerships with leading medical imaging and consumable device manufacturers
Clinical
Several IOPS cases completed in patients since 2021 commercial launch including the completion of a multi-center study supporting the efficacy of radiation safety
Advisors
Support from thought leaders across aortic, structural heart, neurovascular and peripheral spaces
Research
Published in Endovascular Today, Journal of Vascular Surgery, and International Society of Endovascular Specialties
Grants
Recipient of 4 NIH Grants
Awards
Received numerous technical and leadership awards in medical device technology development
CONTACT & LEARN MORE